These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10145140)

  • 21. Costs, effects and cost-effectiveness of breast cancer control in Ghana.
    Zelle SG; Nyarko KM; Bosu WK; Aikins M; Niëns LM; Lauer JA; Sepulveda CR; Hontelez JA; Baltussen R
    Trop Med Int Health; 2012 Aug; 17(8):1031-43. PubMed ID: 22809238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Value of a short-term imaging follow-up after a benign result in a one-stop breast unit: Is it still useful?
    Daroles J; Borget I; Suciu V; Mazouni C; Delaloge S; Balleyguier C
    Eur J Cancer; 2017 Nov; 85():23-30. PubMed ID: 28881248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Value Analysis of Digital Breast Tomosynthesis for Breast Cancer Screening in a US Medicaid Population.
    Miller JD; Bonafede MM; Herschorn SD; Pohlman SK; Troeger KA; Fajardo LL
    J Am Coll Radiol; 2017 Apr; 14(4):467-474.e5. PubMed ID: 28139412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of breast cancer screening in women on dialysis.
    Wong G; Howard K; Chapman JR; Craig JC
    Am J Kidney Dis; 2008 Nov; 52(5):916-29. PubMed ID: 18789566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Personalized Mammography Screening and Screening Adherence-A Simulation and Economic Evaluation.
    Arnold M; Quante AS
    Value Health; 2018 Jul; 21(7):799-808. PubMed ID: 30005752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cost-effectiveness of screening mammography beyond age 65 years: a systematic review for the U.S. Preventive Services Task Force.
    Mandelblatt J; Saha S; Teutsch S; Hoerger T; Siu AL; Atkins D; Klein J; Helfand M;
    Ann Intern Med; 2003 Nov; 139(10):835-42. PubMed ID: 14623621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Health economics analysis of breast cancer screening].
    Boncz I; Sebestyén A; Gulácsi L; Pál M; Dózsa C
    Magy Onkol; 2003; 47(2):149-54. PubMed ID: 12975661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness of the Norwegian breast cancer screening program.
    van Luijt PA; Heijnsdijk EA; de Koning HJ
    Int J Cancer; 2017 Feb; 140(4):833-840. PubMed ID: 27861849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential Cost Savings of Contrast-Enhanced Digital Mammography.
    Patel BK; Gray RJ; Pockaj BA
    AJR Am J Roentgenol; 2017 Jun; 208(6):W231-W237. PubMed ID: 28379734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cost-effectiveness analysis of breast cancer screening with mammography].
    Iinuma T
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():226-8. PubMed ID: 17682158
    [No Abstract]   [Full Text] [Related]  

  • 31. Health economic analysis of Breast Cancer Index in patients with ER+, LN- breast cancer.
    Gustavsen G; Schroeder B; Kennedy P; Pothier KC; Erlander MG; Schnabel CA; Ali H
    Am J Manag Care; 2014 Aug; 20(8):e302-10. PubMed ID: 25295793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Costs and benefits of diagnosing familial breast cancer.
    Heimdal K; Maehle L; Møller P
    Dis Markers; 1999 Oct; 15(1-3):167-73. PubMed ID: 10595273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relative economics of screening for colorectal cancer, breast cancer and cervical cancer.
    Gyrd-Hansen D
    Crit Rev Oncol Hematol; 1999 Nov; 32(2):133-44. PubMed ID: 10612013
    [No Abstract]   [Full Text] [Related]  

  • 34. Cost-effectiveness of annual versus biennial screening mammography for women with high mammographic breast density.
    Pataky R; Ismail Z; Coldman AJ; Elwood M; Gelmon K; Hedden L; Hislop G; Kan L; McCoy B; Olivotto IA; Peacock S
    J Med Screen; 2014 Dec; 21(4):180-8. PubMed ID: 25186116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Population-Based Study to Determine the Health System Costs of Using the 21-Gene Assay.
    Mittmann N; Earle CC; Cheng SY; Julian JA; Rahman F; Seung SJ; Levine MN
    J Clin Oncol; 2018 Jan; 36(3):238-243. PubMed ID: 29193984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening fundamentals.
    Smith RA
    J Natl Cancer Inst Monogr; 1997; (22):15-9. PubMed ID: 9709269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Definitions of cost, benefit divide breast cancer researchers.
    Lowers J
    Qual Lett Healthc Lead; 1997 Dec; 9(11):15. PubMed ID: 10176023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mammography screening under 50: a limited perspective on a multifaceted issue.
    Royak-Schaler R; Gallant SJ; Klabunde CN
    Womens Health; 1996; 2(4):243-9; discussion 261-6. PubMed ID: 9421559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modelling the future costs of breast screening.
    Johnston K
    Eur J Cancer; 2001 Sep; 37(14):1752-8. PubMed ID: 11549428
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.